US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long AMAT ETF

27.04

+1.766.96%

Post-market: 27.290.2500+0.92%19:58 EDT

Volume:349.03K

Turnover:9.40M

Market Cap:43.26M

PE:- -

High:27.48

Open:25.72

Low:25.72

Close:25.28

52wk High:62.00

52wk Low:16.64

Shares:1.60M

Float Shares:1.60M

Volume Ratio:1.78

T/O Rate:21.81%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Texas Cardiac Arrhythmia Institute at St. David's Medical Center to host international conference on complex cardiac arrhythmias

SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System

DeFi Development Corp. to Host X Spaces Event: “DFDV April 2026 Recap & AMA”

Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026

Press Release: QT Imaging Reports First Quarter 2026 Revenue of $6.5 Million

NASDAQ New 52-Week Highs And Lows

AMA Group Proposes to Buy Back Nearly 48 Million Shares

MT Newswires Live

Morgans Remains a Buy on Ama Group Limited (AMA)

AMA Group Posts Lower Fiscal Q3 EBITDA, Higher Revenue, Shares Up 8%

MT Newswires Live

AMA Group lifts margins, confirms FY26 guidance and launches buyback plan

Why Is Plus Therapeutics Stock Gaining Friday?

Benzinga_recent_news

Bell Potter Keeps Their Buy Rating on Ama Group Limited (AMA)

Plus CNSide Cerebrospinal Fluid Tumor Cell Enumeration test gets AMA PLA code

Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/AMA/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AMA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMA\",,,,,undefined,":{"symbol":"AMA","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long AMAT ETF","latestPrice":27.04,"timestamp":1790884800000,"preClose":25.28,"halted":0,"volume":349033,"hourTrading":{"tag":"盘后","latestPrice":27.29,"preClose":27.04,"latestTime":"19:58 EDT","volume":6869,"amount":185943.347,"timestamp":1790899118494,"change":0.25,"changeRate":0.009246,"amplitude":0.018502},"delay":0,"changeRate":0.06962025316455688,"floatShares":1600000,"shares":1600000,"eps":0,"marketStatus":"Not Yet Opened","change":1.76,"latestTime":"10-01 16:00:00 EDT","open":25.72,"high":27.4799,"low":25.72,"amount":9397481.069022,"amplitude":0.069616,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790928000000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":25.28,"nav":25.31,"aum":40496000,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":25.83,"preClose":25.28,"latestTime":"09:28 EDT","volume":10567,"amount":282461.225201,"timestamp":1790861307229,"change":0.55,"changeRate":0.021756,"amplitude":0.043117},"postHourTrading":{"tag":"盘后","latestPrice":27.29,"preClose":27.04,"latestTime":"19:58 EDT","volume":6869,"amount":185943.347,"timestamp":1790899118494,"change":0.25,"changeRate":0.009246,"amplitude":0.018502},"volumeRatio":1.77721},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMA\",,,,,undefined,":{"symbol":"AMA","floatShares":1600000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.77721,"shares":1600000,"dividePrice":0,"high":27.4799,"amplitude":0.069616,"preClose":25.28,"low":25.72,"week52Low":16.64,"pbRate":"--","week52High":62,"institutionHeld":0,"latestPrice":27.04,"eps":0,"divideRate":0,"volume":349033,"delay":0,"ttmEps":0,"open":25.72,"prevYearClose":20.33,"prevWeekClose":22.8428,"prevMonthClose":25.28,"prevQuarterClose":25.28,"fiveDayClose":21.93,"twentyDayClose":19.23,"sixtyDayClose":35.95},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AMA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AMA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AMA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AMA\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2637312560","title":"Texas Cardiac Arrhythmia Institute at St. David's Medical Center to host international conference on complex cardiac arrhythmias","url":"https://stock-news.laohu8.com/highlight/detail?id=2637312560","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637312560?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:08","pubTimestamp":1779455280,"startTime":"0","endTime":"0","summary":"EPLive 2026 is a two-day conference that draws the world's top cardiac electrophysiology experts. AUSTIN, Texas, May 22, 2026 /PRNewswire/ -- The Texas Cardiac Arrhythmia Institute  at St. David's Medical Center will host its eighth international symposium on complex arrhythmias on May 28-29, 2026. EPLive, held biennially since 2012, is an intensive, two-day educational meeting for physicians, advanced practice registered nurses and allied health professionals who have an interest in treating complex cardiac arrhythmias, a condition in which the heart beats with an irregular or abnormal rhythm. Live cases, which are broadcast with expert commentary from the state-of-the-art Electrophysiology Center at St. David's Medical Center, will serve as the primary teaching tool.The conference will also focus on a variety of objectives, including:","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/texas-cardiac-arrhythmia-institute-at-st-davids-medical-center-to-host-international-conference-on-complex-cardiac-arrhythmias-302779949.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMA","LAA.AU","VT","BK4107","TCAI","BK4585","AMA.AU","PRA","BK7064","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636073386","title":"SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System","url":"https://stock-news.laohu8.com/highlight/detail?id=2636073386","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636073386?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:00","pubTimestamp":1779105600,"startTime":"0","endTime":"0","summary":"Additional supportive reimbursement pathway for surgeons may enhance patient access to the BIM-IOL System upon potential commercializationALISO VIEJO, Calif., May  18, 2026  (GLOBE NEWSWIRE) -- SpyGla","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/18/3296580/0/en/SpyGlass-Pharma-Announces-New-Add-on-Category-III-CPT-Code-for-Its-Innovative-BIM-IOL-System.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","AMA","III","SGP","BK4215","BK4588","BK4007","BK4134","CPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635853082","title":"DeFi Development Corp. to Host X Spaces Event: “DFDV April 2026 Recap & AMA”","url":"https://stock-news.laohu8.com/highlight/detail?id=2635853082","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635853082?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:30","pubTimestamp":1778848200,"startTime":"0","endTime":"0","summary":"s=20. About DeFi Development Corp.DeFi Development Corp.  has adopted a treasury policy under which the principal holding in its treasury reserve is allocated to SOL. Through this strategy, the Company provides investors with direct economic exposure to SOL, while also actively participating in the growth of the Solana ecosystem. In addition to holding and staking SOL, DeFi Development Corp. operates its own validator infrastructure, generating staking rewards and fees from delegated stake. The Company is also engaged across decentralized finance  opportunities and continues to explore innovative ways to support and benefit from Solana’s expanding application layer. The Company is also an AI-powered online platform that connects the commercial real estate industry by providing value-add services and software subscriptions to multifamily and commercial property professionals, as the Company connects the increasingly complex ecosystem that stakeholders have to manage. The Company’s data ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/15/3295829/0/en/DeFi-Development-Corp-to-Host-X-Spaces-Event-DFDV-April-2026-Recap-AMA.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOLZ","SOLX","HST","BSOL","BK4218","SSK","AMA","CHAD","BK4588","BK4585","GSOL","SLON","BK4181","SOCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635171527","title":"Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2635171527","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635171527?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:30","pubTimestamp":1778761800,"startTime":"0","endTime":"0","summary":"Recent transition to the Full Market Release has already resulted in increased revenue for the current Q2, which has already exceeded Q1 revenue, as utilization and adoption of the LIBERTY System acce","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/14/3294928/0/en/Microbot-Medical-Successfully-Transitions-to-Commercial-Operations-as-It-Records-Revenue-Resulting-from-Its-Limited-Market-Release-During-the-First-Quarter-of-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2720916845.USD","AMA","IE0004086264.USD","IE000MB6IJN5.SGD","LU0823434740.USD","LU2054465674.USD","IE00BFXG0V08.USD","LU0345769128.USD","SG9999001077.SGD","LU0107464264.USD","SG9999011175.SGD","LU0011850046.USD","LU0820561909.HKD","LU1267930730.SGD","LU0390134368.USD","LU2543165471.USD","LU0096362180.USD","LU1868836914.USD","LU2462157665.USD","LU0971096721.USD","BPH","LU0823421416.USD","LU2168564149.EUR","PAE","LU1861217088.USD","LU1803068979.SGD","MA","MBOT","LU0868494617.USD","IE00BKDWB100.SGD","LU2360106780.USD","LU1718418525.SGD","LU2213496289.HKD","LU2361044949.HKD","LU1974910355.USD","LU0127658192.USD","LU1280957306.USD","LU1868837136.USD","BK4585","IE00B5TLWC47.USD","LU0006306889.USD","IE000F7OJYX1.SGD","LU0077335932.USD","BK4534","LU2361044865.SGD","IE00BWXC8680.SGD","LU0109391861.USD","LU0061474705.USD","LU2552382215.SGD","IE00BQXX3F31.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635078427","title":"Press Release: QT Imaging Reports First Quarter 2026 Revenue of $6.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635078427","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635078427?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:15","pubTimestamp":1778674500,"startTime":"0","endTime":"0","summary":"Revenue of $6.5 Million, Up 133% Year-Over-Year with 13 Scanners Shipped. Two Year Extension of the Maturity Date of the Senior Secured Term Loan to March 31, 2029. Secured a Category III CPT Code Specific to QT Imaging, Paving the Way to U.S. Reimbursement. Conference Call Begins Today at 4:30 p.m. Eastern Time. QT Imaging Holdings, Inc.  , a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today reported financial results for the three months ended March 31, 2026 and provided a business update.\"Recently, the maturity date of our senior secured term loan with our lender was extended by two years from March 31, 2027 to March 31, 2029. This extension provides the Company with additional financial flexibility as we continue executing on our commercial, clinical, and strategic growth initiatives.high-risk women and demonstrated absolute agreement between QT Ima","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","BK4588","UAE","BK4099","BK4082","BK4555","03160","BK4604","QTI","AMA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634728058","title":"NASDAQ New 52-Week Highs And Lows","url":"https://stock-news.laohu8.com/highlight/detail?id=2634728058","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634728058?lang=en_us&edition=fundamental","pubTime":"2026-05-11 22:20","pubTimestamp":1778509200,"startTime":"0","endTime":"0","summary":"abrdn Focused US SC Act      AFSC        36.33            931. Astoria US EW Qual Kings     ROE         40.10            457. Burney U.S. Eq Select ETF    BRES        26.59            104. Calamos Conv Hi Inco Fd      CHY         13.00         62,820. Calamos Glbl Tot Ret Fd      CGO         13.60          5,934. Cyber S&P 500 & Solana       SSS         20.99            297. Defiance Tgt 2X Lg AMAT      AMA         24.93        116,720","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2860962120.EUR","LU1880398471.USD","QQQE","LU1064131342.USD","LU0823421333.USD","IE00B5949003.HKD","LU2098885051.SGD","QQQY","AMA","LU1316542783.SGD","LU0823421416.USD","BK4554","QCOM","LU1803068979.SGD","LU2458330243.SGD","BK4573","ONEQ","BK4614","AMDY","INTC","BK4566","LU1242518857.USD","LU0274383776.USD","IE0004445239.USD","BK4605","TQQQ","BK4612","LU0081259029.USD","LU1951198990.SGD","BK4512","LU2089985449.USD","LU2264538146.SGD","AMYY","TQQY","LU2054465674.USD","PSQ","HXC","LU2458330169.SGD","LU1988902786.USD","FTEC","NVIW.SI","LU0056508442.USD","DAMD","LU1242518931.SGD","AMDG","NDAQ",".IXIC","NQmain","SG9999001424.SGD","IE0009356076.USD","QQQM","BK4550","SQQQ","IE00BMPRXN33.USD","QDTE","AMDS","AMDD","QID","AMDL","IYW","LINT","BK4585","04335","IE00BMPRXR70.SGD","LU0719512351.SGD","BK4575","LU0979878070.USD","BK4588","LU0390134368.USD","LU2250418816.HKD","TECS","LU2355687059.USD","LU0889565833.HKD","LU2360106780.USD","QQQJ","GPIQ","LU1861558580.USD","AMDW","LU0127658192.USD","LU1951200564.SGD","QYLG","LU1852331112.SGD","AMUU","LU0823434583.USD","AMDU","LU1861559042.SGD","LU2931357623.SGD","BK4534","NDX","LU1303367103.USD","MNQmain","SOCL","QTOP","LU0642271901.SGD","LU0082616367.USD","AMD","BK4141","LU0109392836.USD","LU0198837287.USD","LU1989764664.SGD","QLD","QCMU","JEPQ","BK4529","LU1923623000.USD","BK4543","LU1880398554.USD","QQQA","LU0823434740.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633106414","title":"AMA Group Proposes to Buy Back Nearly 48 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2633106414","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633106414?lang=en_us&edition=fundamental","pubTime":"2026-05-08 07:55","pubTimestamp":1778198114,"startTime":"0","endTime":"0","summary":"AMA Group (ASX:AMA) is set to buy back a maximum of 47.8 million of its ordinary, fully-paid shares in an on-market repurchase program, according to a Friday Australian bourse filing.The proposed program will start on May 25 and run until May 24, 2027, the filing said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMA.AU","BK7064","AMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629070523","title":"Morgans Remains a Buy on Ama Group Limited (AMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629070523","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629070523?lang=en_us&edition=fundamental","pubTime":"2026-04-23 09:38","pubTimestamp":1776908335,"startTime":"0","endTime":"0","summary":"In a report released today, Jared Gelsomino from Morgans maintained a Buy rating on Ama Group Limited, with a price target of A$0.80. Gelsomino cov...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgans-remains-a-buy-on-ama-group-limited-ama-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgans-remains-a-buy-on-ama-group-limited-ama-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629067005","title":"AMA Group Posts Lower Fiscal Q3 EBITDA, Higher Revenue, Shares Up 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629067005","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629067005?lang=en_us&edition=fundamental","pubTime":"2026-04-22 09:35","pubTimestamp":1776821710,"startTime":"0","endTime":"0","summary":"AMA Group  said unaudited normalized fiscal third-quarter pre-AASB 16 earnings before interest, taxes, depreciation, and amortization  fell to AU$17.9 million from AU$21.1 million in the third quarter of fiscal year 2025, according to a Wednesday Australian bourse filing.Revenue was AU$254.2 million compared to AU$249.6 million in the same period last year.The company said operating cash outflow for the fiscal Q3 was AU$400,000 after all lease costs and a AU$6.3 million income tax payment in March, compared to a AU$5.3 million inflow in the prior corresponding period, which included a significantly lower tax payment of AU$200,000.AMA Group maintained its fiscal year 2026 guidance, with normalized pre-AASB 16 EBITDA expected to be in the range of AU$70 million to AU$75 million, assuming broader geopolitical developments do not materially impact repair volumes.The company's shares rose 8% in recent Wednesday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629506143","title":"AMA Group lifts margins, confirms FY26 guidance and launches buyback plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2629506143","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629506143?lang=en_us&edition=fundamental","pubTime":"2026-04-22 07:48","pubTimestamp":1776815323,"startTime":"0","endTime":"0","summary":"Ama Group Limited ( ($AU:AMA) ) just unveiled an announcement. AMA Group reported unaudited normalised pre-AASB 16 EBITDA of $17.9 million for the ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ama-group-lifts-margins-confirms-fy26-guidance-and-launches-buyback-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ama-group-lifts-margins-confirms-fy26-guidance-and-launches-buyback-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626124661","title":"Why Is Plus Therapeutics Stock Gaining Friday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2626124661","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626124661?lang=en_us&edition=fundamental","pubTime":"2026-04-11 02:12","pubTimestamp":1775844720,"startTime":"0","endTime":"0","summary":"Plus Therapeutics stock jumps after FDA grants Orphan Drug status to Reyobiq for pediatric brain cancer, boosting long-term outlook.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/10/cancer.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/10/cancer.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/fda/26/04/51761810/why-is-plus-therapeutics-stock-gaining-friday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/fda/26/04/51761810/why-is-plus-therapeutics-stock-gaining-friday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["IND","BK4150","CNS","BK4539","BK4007","BK4217","BK4139","RSI","LENZ","AMA","BK4135","SMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626909718","title":"Bell Potter Keeps Their Buy Rating on Ama Group Limited (AMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2626909718","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626909718?lang=en_us&edition=fundamental","pubTime":"2026-04-09 15:06","pubTimestamp":1775718394,"startTime":"0","endTime":"0","summary":"In a report released today, Chris Savage from Bell Potter maintained a Buy rating on Ama Group Limited, with a price target of A$1.20. According to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bell-potter-keeps-their-buy-rating-on-ama-group-limited-ama-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bell-potter-keeps-their-buy-rating-on-ama-group-limited-ama-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625930650","title":"Plus CNSide Cerebrospinal Fluid Tumor Cell Enumeration test gets AMA PLA code","url":"https://stock-news.laohu8.com/highlight/detail?id=2625930650","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625930650?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:55","pubTimestamp":1775562934,"startTime":"0","endTime":"0","summary":"Plus Therapeutics (PSTV) announced that the American Medical Association has approved a new, proprietary laboratory analyses current procedural ter...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/plus-cnside-cerebrospinal-fluid-tumor-cell-enumeration-test-gets-ama-pla-code-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/plus-cnside-cerebrospinal-fluid-tumor-cell-enumeration-test-gets-ama-pla-code-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSTV","AMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625958701","title":"Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption","url":"https://stock-news.laohu8.com/highlight/detail?id=2625958701","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625958701?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:30","pubTimestamp":1775561400,"startTime":"0","endTime":"0","summary":"New dedicated billing code facilitates payer reimbursement, supports clinician adoptions, and enables national utilization trackingHOUSTON, April  07, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/07/3268999/0/en/Plus-Therapeutics-Receives-AMA-PLA-Code-for-CNSide-CSF-Tumor-Cell-Enumeration-Test-Advancing-Reimbursement-and-U-S-Commercial-Adoption.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BK4139","BK4215","AMA","BK4585","BK4007","BK4588","CSF","BK4539","LENZ","CPT","CNS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":9,"totalSize":174,"code":"91000000","status":"200"}]}}